Search results for "Lower respiratory tract infections"


 
Results 1 - 7 of about 7 for "Lower respiratory tract infections".

MKSAP Quiz: Evaluation for cough, wheezing

A 35-year-old woman is evaluated for a cough and wheezing occurring several times during the week, unrelated to exercise. She has a history of asthma that was previously well controlled with a budesonide inhaler. She is also taking albuterol five times weekly with good response. Following a physical exam, what treatment should be started?
https://immattersacp.org/weekly/archives/2024/03/26/3.htm
26 Mar 2024

Warnings on insomnia meds, pacemaker battery depletion

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2019/07/warnings-on-insomnia-meds-pacemaker-battery-depletion.htm
1 Jul 2019

First-line antibiotic resistance may have increased 12% over 2 decades

More than 1 in 10 first-line antibiotic monotherapies for 4 common infections had treatment failure, an overall increase of 12% from 1991 to 2012, an industry-funded study found.
https://immattersacp.org/weekly/archives/2014/09/30/1.htm
30 Sep 2014

IDSA supports neuraminidase inhibitors for flu in specific populations

In the wake of recent systematic reviews critical of anti-flu drugs, the Infectious Diseases Society of America (IDSA) has reaffirmed recommendations on use of neuraminidase inhibitors (NAIs) for treatment of influenza in high-risk patient populations or severe cases.
https://immattersacp.org/weekly/archives/2014/04/29/4.htm
29 Apr 2014

Prescribing for opioid addiction meds, CNS suppressants

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/11/prescribing-for-opioid-addiction-meds-cns-suppressants.htm
1 Nov 2017

Short-term oral corticosteroids no better than placebo at treating lower respiratory tract infection symptoms, study finds

Researchers randomized 199 patients to receive two 20-mg prednisolone tablets and 202 patients to receive placebo once daily for five days, with primary outcomes of duration of moderately bad or worse cough and mean symptom severity on days two and four.
https://immattersacp.org/weekly/archives/2017/08/29/3.htm
29 Aug 2017

Macrolide antibiotics reduce exacerbations but increase antimicrobial resistance in non-cystic fibrosis bronchiectasis

The macrolide antibiotics erythromycin and azithromycin each appear to reduce exacerbations in patients with non-cystic fibrosis bronchiectasis but may also lead to increased antimicrobial resistance, according to two new studies in the March 27 Journal of the American Medical Association.
https://immattersacp.org/weekly/archives/2013/04/02/4.htm
2 Apr 2013

Result Page: Prev   1   Next